Effect of Evolocumab on Progression of Coronary Disease in Statin-Treated Patients

Stephen J. Nicholls; Rishi Puri; Todd J. Anderson; Christie M. Ballantyne; Leslie Cho; John J.P. Kastelein; Wolfgang Köenig; Ransi Somaratne; Helina Kassahun; Jingyuan Yang; Scott M. Wasserman; Robert C. Scott; Imre Ungi; Jakub Podolec; Antonius Oude Ophuis; Jan H. Cornel; Marilyn Borgman; Danielle M. Brennan; Steven E. Nissen

doi:10.1001/jama.2016.16951

Abstract

clinicaltrials.gov Identifier: NCT01813422.

Keywords

MedicineEvolocumabAlirocumabStatinInternal medicinePlaceboPCSK9TolerabilityCardiologyCoronary atherosclerosisCoronary artery diseaseAtheromaIntravascular ultrasoundUrologyGastroenterologyCholesterolAdverse effectLipoproteinPathologyLDL receptor

Affiliated Institutions

Related Publications

Beneficial Effects of Combined Colestipol-Niacin Therapy on Coronary Atherosclerosis and Coronary Venous Bypass Grafts

David H. Blankenhorn

The Cholesterol-Lowering Atherosclerosis Study (CLAS) was a randomized, placebo-controlled, angiographic trial testing combined colestipol hydrochloride and niacin therapy in 16...

1987 JAMA 1643 citations

Effects of Lipid Lowering by Pravastatin on Progression and Regression of Coronary Artery Disease in Symptomatic Men With Normal to Moderately Elevated Serum Cholesterol Levels

J. Wouter Jukema , Albert V.G. Bruschke , Ad J. van Boven +7 more

Background Intensive lowering of serum cholesterol may retard progression of coronary atherosclerosis in selected groups of patients. However, few data are available on the pote...

1995 Circulation 842 citations

Kuopio Atherosclerosis Prevention Study (KAPS)

Riitta Salonen , Kristiina Nyyssönen , Elina Porkkala +4 more

Background The atherosclerotic progression–reducing effect of LDL cholesterol (LDL-C) lowering has been established in subjects with severe atherosclerotic disease but not in pe...

1995 Circulation 543 citations

Effect of Intensive Compared With Moderate Lipid-Lowering Therapy on Progression of Coronary Atherosclerosis

Steven E. Nissen , E. Murat Tuzcu , Paul Schoenhagen +10 more

For patients with coronary heart disease, intensive lipid-lowering treatment with atorvastatin reduced progression of coronary atherosclerosis compared with pravastatin. Compare...

2004 JAMA 2332 citations

The Lipid Research Clinics Coronary Primary Prevention Trial results. II. The relationship of reduction in incidence of coronary heart disease to cholesterol lowering

In the Lipid Research Clinics Coronary Primary Prevention Trial (LRC-CPPT), a 19% lower incidence of coronary heart disease (CHD) in cholestyramine-treated men was accompanied b...

1984 JAMA 644 citations

Publication Info

Year: 2016
Type: article
Volume: 316
Issue: 22
Pages: 2373-2373
Citations: 1067
Access: Closed

External Links

View on DOI.org

Social Impact

Altmetric

Effect of Evolocumab on Progression of Coronary Disease in Statin-Treated Patients

PlumX Metrics

Social media, news, blog, policy document mentions

Citation Metrics

1067

OpenAlex

Cite This

APA Style

                            
                                
                                    Stephen J. Nicholls, 
                                
                                    Rishi Puri, 
                                
                                    Todd J. Anderson
                                
                                et al.
                            
                            (2016). 
                            Effect of Evolocumab on Progression of Coronary Disease in Statin-Treated Patients. 
                            JAMA
                            , 316
                            (22)
                            , 2373-2373.
                            https://doi.org/10.1001/jama.2016.16951
                        

Identifiers

DOI: 10.1001/jama.2016.16951